Abstract
A long-held tenet of cell therapies has been that a biologically relevant dose of cells must be delivered to the site of injury and at least transiently engraft. It naturally follows that strategies to optimize these endpoints would be pursued as a translational goal. Optimization of progenitor cell efficacy requires delivery of the implanted progenitor cells to the site of neurological injury without significant effect on cell viability and function. An ideal delivery vehicle would provide high levels of cellular engraftment without affecting viability. Delivery vehicles include intravenous infusion, intra-arterial infusion, direct implantation (with or without synthetic scaffolds), and intrathecal infusion. In addition, preliminary investigation into novel forms of delivery such as cellular manipulation to improve engraftment and the seeding of extruded biocompatible polymer nanofiber scaffolds is under way. We will discuss the potential benefits and untoward effects associated with each method of delivery. Also, emerging data suggest that the tenet of local delivery/engraftment to achieve a positive biological effect is cell type-specific and not necessary in all circumstances.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CNS:
-
Central nervous system
- FDA:
-
US Food and Drug Administration
- HSC:
-
Hematopoietic stem cell
- hUCBC:
-
Human umbilical cord blood cell
- IL:
-
Interleukin
- MAPC:
-
Multipotent adult progenitor cell
- MCAO:
-
Middle cerebral artery occlusion
- MSC:
-
Mesenchymal stromal cell
- NF-κB:
-
Nuclear factor-kappa-B
- NGF:
-
Nerve growth factor
- NgR-Ab:
-
Nogo receptor antibody
- NSC:
-
Neural stem cell
- PLL:
-
Poly-l-lysine
- SDF-1:
-
Stromal cell-derived factor-1
- TBI:
-
Traumatic brain injury
- TLR:
-
Toll-like receptor
References
Allers C, Sierralta WD, Neubauer S, Rivera F, Minguell JJ, Conget PA (2004) Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation 78:503–508
Bachstetter AD, Pabon MM, Cole MJ, Hudson CE, Sanberg PR, Willing AE, Bickford PC, Gemma C (2008) Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain. BMC Neurosci 9:22
Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, Moretta A, Montagna D, Maccario R, Villa R, Daidone MG, Zuffardi O, Locatelli F (2007) Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67:9142–9149
Bible E, Chau DY, Alexander MR, Price J, Shakesheff KM, Modo M (2009) The support of neural stem cells transplanted into stroke-induced brain cavities by PLGA particles. Biomaterials 30:2985–2994
Boomsma RA, Swaminathan PD, Geenen DL (2007) Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size. Int J Cardiol 122:17–28
Castro RF, Jackson KA, Goodell MA, Robertson CS, Liu H, Shine HD (2002) Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science 297:1299
Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M (2001) Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32:2682–2688
Choumerianou DM, Dimitriou H, Perdikogianni C, Martimianaki G, Riminucci M, Kalmanti M (2008) Study of oncogenic transformation in ex vivo expanded mesenchymal cells, from paediatric bone marrow. Cell Prolif 41:909–922
Coyne TM, Marcus AJ, Woodbury D, Black IB (2006) Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells 24:2483–2492
Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R (2003) Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101:2999–3001
El Khoury R, Misra V, Sharma S, Cox CS, Walker P, Grotta JC, Gee A, Suzuki S, Savitz SI (2010) The effect of transcatheter injections on cell viability and cytokine release of mononuclear cells. AJNR Am J Neuroradiol Apr 15 31(8):1488–92
Elmadbouh I, Haider H, Jiang S, Idris NM, Lu G, Ashraf M (2007) Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol 42:792–803
Fan L, Du F, Cheng BC, Peng H, Liu SQ (2008) Migration and distribution of bone marrow stromal cells in injured spinal cord with different transplantation techniques. Chin J Traumatol 11:94–97
FDA (2009a) Draft guidance for industry: Somatic cell therapy for cardiac disease
FDA (2009b) Guidance for FDA reviewers and sponsors: Content and review of chemistry, manufacturing, and control (CMC) information for human somatic cell therapy Investigation New Drug Applications (INDs)
Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, Laine GA, Cox CS Jr (2008) Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 18(5):683–692
Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, Laine GA, Cox CS Jr (2009) Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 18:683–692
Flax JD, Aurora S, Yang C, Simonin C, Wills AM, Billinghurst LL, Jendoubi M, Sidman RL, Wolfe JH, Kim SU, Snyder EY (1998) Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat Biotechnol 16:1033–1039
Fujiwara Y, Tanaka N, Ishida O, Fujimoto Y, Murakami T, Kajihara H, Yasunaga Y, Ochi M (2004) Intravenously injected neural progenitor cells of transgenic rats can migrate to the injured spinal cord and differentiate into neurons, astrocytes and oligodendrocytes. Neurosci Lett 366:287–291
Griffith LG, Naughton G (2002) Tissue engineering – current challenges and expanding opportunities. Science 295:1009–1014
Guillot PV, Cui W, Fisk NM, Polak DJ (2007) Stem cell differentiation and expansion for clinical applications of tissue engineering. J Cell Mol Med 11:935–944
Guzman R, De Los Angeles A, Cheshier S, Choi R, Hoang S, Liauw J, Schaar B, Steinberg G (2008) Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model. Stroke 39:1300–1306
Harting MT, Jimenez F, Cox CS Jr (2008) The pulmonary first-pass effect, xenotransplantation and translation to clinical trials – a commentary. Brain 131:e100; author reply e101
Harting MT, Jimenez F, Xue H, Fischer UM, Baumgartner J, Dash PK, Cox CS (2009a) Intravenous mesenchymal stem cell therapy for traumatic brain injury. J Neurosurg 110:1189–1197
Harting MT, Jimenez F, Xue H, Fischer UM, Baumgartner J, Dash PK, Cox CS (2009b) Intravenous mesenchymal stem cell therapy for traumatic brain injury. J Neurosurg 110(6):1189–1197
Harting MT, Sloan LE, Jimenez F, Baumgartner J, Cox CS Jr (2009c) Subacute neural stem cell therapy for traumatic brain injury. J Surg Res 153:188–194
Hung SC, Pochampally RR, Hsu SC, Sanchez C, Chen SC, Spees J, Prockop DJ (2007) Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS ONE 2:e416
Isakova IA, Baker K, DuTreil M, Dufour J, Gaupp D, Phinney DG (2007) Age- and dose-related effects on MSC engraftment levels and anatomical distribution in the central nervous systems of nonhuman primates: identification of novel MSC subpopulations that respond to guidance cues in brain. Stem Cells 25:3261–3270
Jen AC, Wake MC, Mikos AG (1996) Review: Hydrogels for cell immobilization. Biotechnol Bioeng 50:357–364
Jongpaiboonkit L, King WJ, Murphy WL (2008) Screening for 3D environments that support human mesenchymal stem cell viability using hydrogel arrays. Tissue Eng Part A 15(2):343–353
Klouda L, Mikos AG (2008) Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm 68:34–45
Kopecek J (2007) Hydrogel biomaterials: a smart future? Biomaterials 28:5185–5192
Langer R, Vacanti JP (1993) Tissue engineering. Science 260:920–926
Lappalainen RS, Narkilahti S, Huhtala T, Liimatainen T, Suuronen T, Narvanen A, Suuronen R, Hovatta O, Jolkkonen J (2008) The SPECT imaging shows the accumulation of neural progenitor cells into internal organs after systemic administration in middle cerebral artery occlusion rats. Neurosci Lett 440:246–250
Lee ST, Chu K, Jung KH, Kim SJ, Kim DH, Kang KM, Hong NH, Kim JH, Ban JJ, Park HK, Kim SU, Park CG, Lee SK, Kim M, Roh JK (2008) Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 131:616–629
Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ (2009) Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5:54–63
Liao S, Li B, Ma Z, Wei H, Chan C, Ramakrishna S (2006) Biomimetic electrospun nanofibers for tissue regeneration. Biomed Mater 1:R45–R53
Liao W, Xie J, Zhong J, Liu Y, Du L, Zhou B, Xu J, Liu P, Yang S, Wang J, Han Z, Han ZC (2009) Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation 87:350–359
Liu W, Jiang X, Fu X, Cui S, Du M, Cai Y, Xu R (2008) Bone marrow stromal cells can be delivered to the site of traumatic brain injury via intrathecal transplantation in rabbits. Neurosci Lett 434:160–164
Lu D, Li Y, Wang L, Chen J, Mahmood A, Chopp M (2001a) Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury. J Neurotrauma 18:813–819
Lu D, Mahmood A, Wang L, Li Y, Lu M, Chopp M (2001b) Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport 12:559–563
Lu D, Sanberg PR, Mahmood A, Li Y, Wang L, Sanchez-Ramos J, Chopp M (2002) Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant 11:275–281
Mahmood A, Lu D, Wang L, Li Y, Lu M, Chopp M (2001) Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells. Neurosurgery 49:1196–1203; discussion 1203–1194
Mahmood A, Lu D, Wang L, Chopp M (2002) Intracerebral transplantation of marrow stromal cells cultured with neurotrophic factors promotes functional recovery in adult rats subjected to traumatic brain injury. J Neurotrauma 19:1609–1617
Mahmood A, Lu D, Chopp M (2004) Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain. Neurosurgery 55:1185–1193
Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E (2009) Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15:42–49
Nisbet DR, Crompton KE, Horne MK, Finkelstein DI, Forsythe JS (2008a) Neural tissue engineering of the CNS using hydrogels. J Biomed Mater Res B Appl Biomater 87:251–263
Nisbet DR, Moses D, Gengenbach TR, Forsythe JS, Finkelstein DI, Horne MK (2008b) Enhancing neurite outgrowth from primary neurones and neural stem cells using thermoresponsive hydrogel scaffolds for the repair of spinal cord injury. J Biomed Mater Res A 89(1):24–35
Ohta M, Suzuki Y, Noda T, Ejiri Y, Dezawa M, Kataoka K, Chou H, Ishikawa N, Matsumoto N, Iwashita Y, Mizuta E, Kuno S, Ide C (2004) Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol 187:266–278
Pan L, Ren Y, Cui F, Xu Q (2009) Viability and differentiation of neural precursors on hyaluronic acid hydrogel scaffold. J Neurosci Res 87(14):3207–3020
Park KI, Teng YD, Snyder EY (2002) The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol 20:1111–1117
Philips MF, Mattiasson G, Wieloch T, Bjorklund A, Johansson BB, Tomasevic G, ÂMartinez-Serrano A, Lenzlinger PM, Sinson G, Grady MS, McIntosh TK (2001) Neuroprotective and behavioral efficacy of nerve growth factor-transfected hippocampal progenitor cell transplants after experimental traumatic brain injury. J Neurosurg 94:765–774
Potapova IA, Brink PR, Cohen IS, Doronin SV (2008) Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells. J Biol Chem 283:13100–13107
Purcell EK, Seymour JP, Yandamuri S, Kipke DR (2009a) In vivo evaluation of a neural stem cell-seeded prosthesis. J Neural Eng 6:026005
Purcell EK, Singh A, Kipke DR (2009b) Alginate Composition Effects on a Neural Stem Cell-Seeded Scaffold. Tissue Eng Part C Methods 15(4):541–550
Riess P, Zhang C, Saatman KE, Laurer HL, Longhi LG, Raghupathi R, Lenzlinger PM, Lifshitz J, Boockvar J, Neugebauer E, Snyder EY, McIntosh TK (2002) Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury. Neurosurgery 51:1043–1052; discussion 1052–1044
Roybon L, Ma Z, Asztely F, Fosum A, Jacobsen SE, Brundin P, Li JY (2006) Failure of transdifferentiation of adult hematopoietic stem cells into neurons. Stem Cells 24:1594–1604
Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC, Lloyd AC, Bernad A (2005) Spontaneous human adult stem cell transformation. Cancer Res 65:3035–3039
Sands RW, Mooney DJ (2007) Polymers to direct cell fate by controlling the microenvironment. Curr Opin Biotechnol 18:448–453
Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP (2007) Stem cell transplantation: the lung barrier. Transplant Proc 39:573–576
Shen LH, Li Y, Chen J, Zhang J, Vanguri P, Borneman J, Chopp M (2006) Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience 137:393–399
Shetty AK, Rao MS, Hattiangady B (2008) Behavior of hippocampal stem/progenitor cells following grafting into the injured aged hippocampus. J Neurosci Res 86:3062–3074
Shi M, Li J, Liao L, Chen B, Li B, Chen L, Jia H, Zhao RC (2007) Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica 92:897–904
Tomchuck SL, Zwezdaryk KJ, Coffelt SB, Waterman RS, Danka ES, Scandurro AB (2008) Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 26:99–107
Vendrame M, Cassady J, Newcomb J, Butler T, Pennypacker KR, Zigova T, Sanberg CD, Sanberg PR, Willing AE (2004) Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 35:2390–2395
Vendrame M, Gemma C, de Mesquita D, Collier L, Bickford PC, Sanberg CD, Sanberg PR, Pennypacker KR, Willing AE (2005) Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev 14:595–604
Wagers AJ, Sherwood RI, Christensen JL, Weissman IL (2002) Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297:2256–2259
Walczak P, Zhang J, Gilad AA, Kedziorek DA, Ruiz-Cabello J, Young RG, Pittenger MF, van Zijl PC, Huang J, Bulte JW (2008) Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 39:1569–1574
Walker PA, Harting MT, Jimenez F, Shah SK, Pati S, Dash PK, Cox CS (2009a) Direct intrathecal implantation of mesenchymal stromal cells leads to enhanced neuroprotection via an NFkappaB mediated increase in Interleukin 6 (IL-6) production. Stem Cells Dev 19(6):867–876
Walker PA, Shah SK, Harting MT, Cox CS (2009b) Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation. Dis Model Mech 2:23–38
Willerth SM, Sakiyama-Elbert SE (2007) Approaches to neural tissue engineering using scaffolds for drug delivery. Adv Drug Deliv Rev 59:325–338
Zawadzka M, Lukasiuk K, Machaj EK, Pojda Z, Kaminska B (2009) Lack of migration and neurological benefits after infusion of umbilical cord blood cells in ischemic brain injury. Acta Neurobiol Exp (Wars) 69:46–51
Zhao J, Zhang N, Prestwich GD, Wen X (2008) Recruitment of endogenous stem cells for tissue repair. Macromol Biosci 8:836–842
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Walker, P.A. (2011). Stem Cell Delivery Methods and Routes. In: Charles, S. (eds) Progenitor Cell Therapy for Neurological Injury. Stem Cell Biology and Regenerative Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-965-9_3
Download citation
DOI: https://doi.org/10.1007/978-1-60761-965-9_3
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-964-2
Online ISBN: 978-1-60761-965-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)